Herbal Dispatch Inc. reports developments in cannabis e-commerce and distribution, including medical cannabis platforms, direct-to-consumer ordering, and product-channel expansion. Company updates have covered HerbalDispatch.com, the HeroDispatch platform for veterans and insured medical patients, concierge-style support, clinic integration, and insurance-backed purchasing.
Recurring news themes include growth in veteran customer acquisition, enhancements to Shopify-based e-commerce infrastructure, the Chomp Edibles brand, operating and financial results, capital-structure updates such as DTC eligibility, and governance changes tied to board leadership and strategic oversight.
Herbal Dispatch (OTCQB: LUFFF) announced its common shares are now eligible for electronic clearing and settlement through the Depository Trust Company (DTC), improving accessibility for U.S. investors and expected to enhance liquidity and visibility in North America. The company also engaged a market maker and extended certain marketing partner agreements to June 30, 2026.
The company confirmed allocated marketing capital remains available and deferred campaign execution pending DTC eligibility; market making services will be provided for a monthly fee of $5,000.
Herbal Dispatch (OTCQB: LUFFF) amended its unsecured convertible debentures, extending the maturity date from January 31, 2026 to January 31, 2028. All other terms remain: 14% annual interest, conversion price CAD$0.06, and threshold price CAD$0.12.
The company obtained a CSE exemption for certain amendment requirements and relied on MI 61-101 exemptions for formal valuation and minority approval as the fair market values were under 25% of market capitalization. Both director-noteholders abstained from the Board vote; no material change report was filed 21 days prior due to ongoing negotiations.
Herbal Dispatch (OTCQB: LUFFF) announced that its common shares commenced trading on the OTCQB Venture Market effective January 26, 2026 under the ticker LUFFF. The listing is intended to enhance accessibility for U.S. investors, broaden North American exposure, and complement the company’s primary CSE listing (HERB) and Frankfurt listing (HA9). Management said the OTCQB listing may improve liquidity and visibility for U.S. shareholders and supports the company’s capital markets strategy amid renewed investor interest tied to U.S. federal policy momentum on cannabis rescheduling. Investors are directed to the company investor page for reports and updates.
Herbal Dispatch (OTC: LUFFF) reported operational milestones for 2025, including a third consecutive year of double-digit annual sales growth. Preliminary Q4 2025 gross sales were $6.2M (214% vs Q4 2024), and preliminary fiscal 2025 gross sales were $16.5M (38% vs $12.0M in 2024). The company completed an oversubscribed $2.0M private placement in October and launched multiple in-house brands (flower, pre-rolls, vape). The company said Q4 gross margins are expected to be similar to recent quarters and outlined 2026 strategic priorities targeting veteran medical sales, 40% YoY recreational growth, expanded BC SKUs, and tripling exports by 2028.
Herbal Dispatch (OTC Pink: LUFFF) CEO Philip Campbell commented on the U.S. rescheduling of cannabis from Schedule I to Schedule III, calling it a transformative development with global implications for medical research and cross‑border market harmonization.
The company said the change could create strategic partnership and market access opportunities between U.S. and Canadian markets and said it may improve capital access for technology and supply‑chain investments. The release also discloses paid promotional engagements and compensation details to comply with CSE policy.
Herbal Dispatch (OTC: LUFFF) announced a Strategic Business Plan for 2026 targeting accelerated revenue, improved gross margins and EBITDA via four priorities: 1) grow medical cannabis sales to veterans (targeting 200% annual increase, 30% YoY veteran acquisition, >89% retention); 2) expand recreational presence (targeting 40% YoY recreational growth, BC SKUs from 44 to 100+, BC share target 15%); 3) scale B2B exports (aim to triple export volumes by 2028 and 100% YoY export revenue); and 4) increase investor awareness via IR firms. The company completed a $2.0M private placement in Oct 2025 and allocated ~CAD $410,000 for agency programs funded from working capital.
Herbal Dispatch (OTC Pink: LUFFF) announced a retail launch update dated November 25, 2025 for its limited-edition 2025 Happy Hour Cannabis Advent Calendar titled "The Twelve Days of Christmas."
All units supplied to British Columbia retailers via the company's Direct Delivery platform and BC Central Distribution have sold out. The 12-pack contains half-gram pre-rolls from four indica or indica-dominant strains with THC levels up to 31%, each sealed in its own tube and produced using RollPros Blackbird technology. The company said it plans a national expansion in 2026 and will continue sourcing from legacy cultivators while selling via BC direct-to-consumer and national wholesale channels.
Herbal Dispatch (OTC Pink: LUFFF) reported a record month with $4.1M gross sales in October 2025, a 273% increase versus the Q3 2025 average of $1.1M. The company updated its Q4 2025 sales forecast to $6.4M–$7.0M, implying up to a 112% rise versus Q3 2025's $3.3M. Management attributes October strength to recreational cannabis demand, distribution disruptions in British Columbia, domestic expansion, stronger international partnerships, and new e-commerce product launches. The company says it is well capitalized, expects to maintain recent gross margins, and will file full Q3 financial results on SEDAR in the coming weeks.
Herbal Dispatch (OTC Pink: LUFFF) appointed Jay Wilgar as a Strategic Advisor on October 30, 2025.
Wilgar brings 20 years of startup and cannabis-sector experience, including raising over $150 million and leading a $260 million sale of Newstrike Brands to Hexo. The company said his advisory role will support scaling Herbal Dispatch's e-commerce distribution, producer standards, and international expansion.